Health care-associated pneumonia in haemodialysis patients: Clinical outcomes in patients treated with narrow versus broad spectrum antibiotic therapy

Respirology

Volumn 18, Issue 2, 2013, Pages 364-368

  Taylor, Stephanie Parks ^a   Taylor, Brice T ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

antibiotic guideline; bacteriology; haemodialysis; health care associated pneumonia

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHARLSON COMORBIDITY INDEX; COMMUNITY ACQUIRED PNEUMONIA; HEALTH CARE ASSOCIATED PNEUMONIA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; COHORT STUDIES; CROSS INFECTION; HUMANS; LENGTH OF STAY; MIDDLE AGED; PNEUMONIA; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872826509     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02306.x     Document Type: Article

References (13)

1. U.S. Renal Data System (USRDS). USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2009.
2. Hospital-Acquired Pneumonia Guideline Committee of the American Thoracic Society Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005; 171: 388-416.
3. Slinin FRN, Collins AJ,. Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Kidney Int. 2006; 70: 1135-41. (Pubitemid 44344085)
4. Guo H, Liu J, Collins AJ, et al,. Pneumonia in incident dialysis patients-the United States Renal Data System. Nephrol. Dial. Transplant. 2008; 23: 680-6. (Pubitemid 351767600)
5. Garcia-Vidal C, Viasus D, Roset A, et al,. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin. Microbiol. Infect. 2011; 17 (11): 1659-65.
6. Kawasaki S, Aoki N, Kikuchi H, et al,. Clinical and microbiological evaluation of hemodialysis-associated pneumonia (HDAP): should HDAP be included in healthcare-associated pneumonia? J. Infect. Chemother. 2011; 17 (5): 640-5.
7. Seymann GB, Di Francesco L, Sharpe B, et al,. The HCAP gap: differences between self-reported practice patterns and published guidelines for health care-associated pneumonia. Clin. Infect. Dis. 2009; 49 (12): 1868-74.
8. Mandell LA, Wunderink RG, Anzueto A, et al,. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44 (Suppl 2): S27-S72. (Pubitemid 46290553)
9. Fine MJ, Auble TE, Yealy DM, et al,. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 1997; 336: 243-50. (Pubitemid 27044625)
10. Charlson ME, Pompei P, Ales KL, et al,. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987; 40: 373-83. (Pubitemid 17055592)
11. Micek ST, Kollef KE, Reichley RM, et al,. Health care-associated pneumonia and community-acquired pneumonia: A single-center experience. Antimicrob. Agents Chemother. 2007; 51: 3568-73. (Pubitemid 47519345)
12. Zilberberg M, Shorr A, Micek S, et al,. Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: A single-center experience. Chest 2008; 134: 963-8.
13. Umeki K, Tokimatsu I, Yasuda C, et al,. Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia. Respirology 2011; 16: 856-62.